Repurposing antidiabetic drugs for rheumatoid arthritis: results from a  two-sample Mendelian randomization study

Repurposing antidiabetic drugs for rheumatoid arthritis: results from a two-sample Mendelian randomization study

4.6
(748)
Write Review
More
$ 25.00
Add to Cart
In stock
Description

Splicing of PADI4 contributes to RA risk.

PDF) Repurposing antidiabetic drugs for rheumatoid arthritis: results from a two-sample Mendelian randomization study

Effect of pioglitazone on rheumatoid arthritis disease activity

Repurposing antidiabetic drugs for rheumatoid arthritis: results from a two-sample Mendelian randomization study

S-LDSC analysis suggested similar causal variant distributions in

Leonid Padyukov Karolinska Institutet

Associations Between Thiazolidinediones Use and Incidence of Rheumatoid Arthritis: A Retrospective Population‐Based Cohort Study - Zhao - Arthritis Care & Research - Wiley Online Library

Chenxi Qin Karolinska Institutet

EUR J EPIDEMIOL:抗糖尿病药物预防风湿性关节炎的潜力如何?

Chronic inflammatory disease epidemiology – Research group Johan Askling

Splicing and total expression of IL6R jointly contribute to RA risk.

Chronic inflammatory disease epidemiology – Research group Johan Askling